• April 18, 2022

INDICAID COVID-19 Rapid Antigen Test – Instructions for Use

As the COVID-19 pandemic advances, there is a rising requirement for fast, open examines for SARS-CoV-2 location. We present a clinical assessment and genuine execution of the INDICAID COVID-19 quick antigen test (INDICAID fast test). A multisite clinical assessment of the INDICAID quick test utilizing tentatively gathered nasal (two-sided foremost) swab tests from suggestive subjects was performed.

The INDICAID quick test exhibited a positive percent understanding (PPA) and negative percent arrangement (NPA) of 85.3% (95% certainty span [95% CI], 75.6% to 91.6%) and 94.9% (95% CI, 91.6% to 96.9%), individually, contrasted with research center based switch transcriptase PCR (RT-PCR) utilizing nasal examples.

The INDICAID fast test was then carried out at COVID-19 flare-up screening habitats in Hong Kong as a feature of a testing calculation (named “double track”) to evaluate asymptomatic people for prioritization for corroborative RT-PCR testing. In one methodology, fundamental positive INDICAID fast experimental outcomes set off assisted handling for research center based RT-PCR, lessening the typical chance to corroborative outcome from 10.85 h to 7.0 h.

In a subsequent methodology, starter positive outcomes set off ensuing testing with an on location fast RT-PCR, decreasing the normal chance to corroborative outcome to 0.84 h. In 22,994 asymptomatic patients, the INDICAID fast test exhibited a PPA of 84.2% (95% CI, 69.6% to 92.6%) and a NPA of 99.9% (95% CI, 99.9% to 100 percent)

  • contrasted with lab based RT-PCR utilizing consolidated nasal/oropharyngeal examples.
  • The INDICAID quick test has astounding execution contrasted with research center based RT-PCR testing and, when utilized pair with RT-PCR, decreases the opportunity to corroborative positive outcome.

Significance Laboratory-based RT-PCR, the ongoing highest quality level for COVID-19 testing, can require a completion time of 24 to 48 h from test assortment to result. The postponed opportunity as far as possible the adequacy of concentrated RT-PCR testing to diminish transmission and stem expected flare-ups. To address this, we directed a careful assessment of the INDICAID COVID-19 quick antigen test, a 20-minute fast antigen test, in both suggestive and asymptomatic populaces.

The INDICAID quick test showed high awareness and explicitness with RT-PCR as the comparator technique. A double track testing calculation was additionally assessed using the INDICAID quick test to evaluate for fundamental positive patients, whose examples were then focused on for RT-PCR testing. The double track technique showed huge upgrades in assisting the announcing of positive RT-PCR test results contrasted with standard RT-PCR testing without prioritization, offering a superior methodology for local area testing and controlling SARS-CoV-2 episodes.


Deals and transportation just accessible in Hong Kong.

INDICAID COVID-19 Rapid Antigen Test (FDA EUA, CE) is a sidelong stream immunoassay intended for the subjective location of SARS-CoV-2 antigens in direct nasal swab tests. Find out additional.

Item Benefits

Quick: Intuitive visual outcomes shortly
Exact : Clinically approved with generally awareness and explicitness at 96% and 99.9% individually
Simple to-Use: No exceptional hardware or offices required
Created in Hong Kong: With solid item quality
Item Certification: The primary COVID-19 item in Greater China that has acquired US FDA EUA and EU CE mark
Variations perceptibility: Able to distinguish the presence of specific COVID-19 variants*
*Discernible variations incorporate Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), Delta Plus (AY.1 and AY.2), and Omicron (B.1.1.529)

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-1 UnScience 1T 9.6 EUR

SARS-CoV-2 Antigen Rapid Test Kit

CoV2Ag-25 UnScience 25T/kit 42 EUR

NOVATest Antigen Rapid Test Kit (For Single Use) (NOVA Test)

nCov-500-01 Atlas Link Technology 1T 162 EUR

NOVATest Antigen Rapid Kit (NOVA Test)

nCov-500 Atlas Link Technology 20 Tests 162 EUR

SARS-CoV-2 Rapid Antigen Test Nasal

9901-NCOV-03G Roche Diagnostics 25 Tests/Kit 112.8 EUR

Human Streptococcus Pneumoniae (SP) Antigen Rapid Test Kit

abx092096-20tests Abbexa 20 tests 477.6 EUR

Avian Influenza Virus Antigen Rapid Test Kit (Colloidal gold)

abx092015-40tests Abbexa 40 tests 518.4 EUR

Coronavirus (SARS-Cov-2) Antigen Rapid Test Device (Saliva)

IOV87952 INVBIO 20T/kit 46.8 EUR

Newcastle Disease Virus Antigen Rapid Test Kit (Colloidal gold)

abx092016-40tests Abbexa 40 tests 518.4 EUR

Human Chlamydia Trachomatis Antigen Rapid Test Kit (Colloidal gold)

abx092049-20tests Abbexa 20 tests 276 EUR

Avian Influenza H5 Virus Antigen Rapid Test Kit (Colloidal gold)

abx092014-40tests Abbexa 40 tests 585.6 EUR

Avian Influenza H7 Virus Antigen Rapid Test Kit (Colloidal gold)

abx092017-40tests Abbexa 40 tests 518.4 EUR

Accu-Tell COVID-19 IgG/IgM Rapid Test

GEN-B352-20tests Accu test 20 tests 283.2 EUR

Accu-Tell COVID-19 IgG/IgM Rapid Test

GEN-B352-40tests Accu test 40 tests 385.2 EUR

TruStrip RDT Anthrax Protective antigen 83 (PA83) Rapid Test cards, 25/pk

800-100-RDT-25 Alpha Diagnostics 1 pk 489.6 EUR

2019-nCoV IgG/IgM Rapid Test Cassette (Whole Blood/Serum/Plasma)

GEN-402-25tests All test 25 tests 292.8 EUR



Gather nasal swab test
Blend test into the cradle arrangement
Add the cradle arrangement into the example well
Peruse the outcome following 20 minutes and something like 25 minutes

Leave a Reply

Your email address will not be published. Required fields are marked *